Search results for: 'oncology case t 221b 45 phase ii or licens'
- Did you mean
- oncology case t 221b 45 phase ii or lucenc
- Related search terms
- Licensing Terms & Agreements In Pharma, Biotech and Diagnostics
- licensing terms agreements in pharma biotech and diagnostics
- licensing term and agreements in pharma biotech and diagnostics
- licensing tech and agreements in pharma biotech and diagnostics
- 221b data alliance review
-
Molecular Diagnostics for Infectious Disease: Market Forecasts by Syndrome, Plex, Place and Country with Analysis and Executive Guides 2025-2029January 2025$6,995.00Infectious Disease Molecular Diagnostics (MDx) Markets | Global coverage | Market size | Actionable insights| Trends | Key companies | Growth forecasts
Learn More -
Respiratory Infection Diagnostics: Market Forecasts by Technology, Plex, Place and Country with Analysis and Executive Guides 2025-2029January 2025$6,995.00Respiratory Infection Diagnostics Markets | Global coverage | Market size | Actionable insights| Trends | Key companies | Growth forecasts
Learn More -
Sepsis Diagnostics: Market Forecasts by Assay, Cause, Product, Place and Country with Analysis and Executive Guides 2025-2029January 2025$6,995.00Sepsis Diagnostics Markets | Global coverage | Market size | Actionable insights| Trends | Key companies | Growth forecasts
Learn More -
Syndromic Multiplex Diagnostics: Strategies and Trends, Market Forecasts by Syndrome, Place, Product and Country with Analysis and Executive Guides 2025-2029January 2025$6,995.00Syndromic Multiplex Diagnostics Markets | Global coverage | Market size | Actionable insights| Trends | Key companies | Growth forecasts
Learn More -
Academic and Non-Profit Partnering Terms and Agreements 2021-2026March 2026$4,995.00Academic and Non-Profit Partnering Terms and Agreements 2021-2026 provides a detailed understanding and analysis of how and why companies enter Academic and Non-Profit partnering deals.
Learn More -
Biomarker Collaboration and Licensing Deals 2016-2025November 2025$3,995.00Biomarker Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Companion Diagnostic Collaboration and Licensing Deals 2010-2025May 2025$3,995.00Companion Diagnostics Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2010 to 2025
Learn More -
Viral Vector Collaboration and Licensing Deals 2016-2025November 2025$3,995.00Viral Vector Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Cancer Diagnostic Collaboration and Licensing Deals 2018-2025November 2025$3,995.00Cancer Diagnostic Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2018 to 2025
Learn More -
Cell Therapy Collaboration and Licensing Deals 2016-2025November 2025$3,995.00Cell Therapy Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More
